iron deficiency anemia
Conditions
Interventions
Experimental group:Pomegranate blood syrup: take after meal, oral, 30 ml, 3 times a day,8 weeks.
Control Group:Shengxuebao mixture: taken orally after meal, 15ml once, 3 times a day,8weeks.
Sponsors
Beijing University of Chinese Medicine Dongzhimen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Subjects who met all the following criteria were enrolled in the study: (1) those who met the diagnostic criteria of iron deficiency anemia western medicine and had mild or moderate degree of anemia, i.e. male 60G/l < HB < 120G/L, female 60G/l < HB < 110G/l; (2) according to the standard of syndrome differentiation of Qi and blood deficiency; (3) when signing the informed consent, 18<= age <=75 years old, gender is not limited; (4) volunteer to participate in the clinical trial, can understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Subjects who met one of the following criteria would not be enrolled in the trial: (1) chronic unexplained diarrhea, chronic enteritis, gastrointestinal tumor, gastric peptic ulcer, no transferrin, gastrointestinal iron deficiency anemia that cause iron absorption and transport disorders; (2) infection, inflammatory disease, connective tissue disease; (3) heart, liver, lung, kidney; (4) the patients who planned operation within 2 months after enrollment; (5) the patients had been treated with iron or other health care products containing iron supplement or blood transfusion within 4 weeks before entering the trial; (6) pregnant, lactating and preparing pregnant women; (7) those who were allergic to the drugs and ingredients used in the trial; (8) participants who had participated or were participating in other clinical trials in the 3 months prior to enrollment; (9) other conditions considered unsuitable by the investigator to participate in a clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Corpuscular Volume;Mean Corpuscular Hemoglobin;Mean Corpuscular Hemoglobin Concentration;Red Blood Cell;Serum Ferritin;Serum Iron;Total Iron-Binding Capacity;Transferrin Saturation;Abdominal fullness and distension;Reduced appetite;Palpitation;Light-headedness;Short of breath;spontaneous perspiration;insomnia; | — |
Countries
China
Contacts
Public ContactHou li
Beijing University of Chinese Medicine Dongzhimen Hospital
Outcome results
None listed